What if the trick to getting cancer immunotherapy to parts of the world that can’t access it is simply lowering the dose? A ...

Izalontamab Brengitecan (Iza-Bren) Demonstrates Statistically Significant and Clinically Meaningful Improvements in Overall ...

A study by the University of Barcelona has discovered why the two main types of lung cancer—adenocarcinoma of the lung and ...

A number of companies presented new data on their cancer vaccine candidates at ASCO 2026.

Yousef and Finger review results of clinical treatment of 101 squamous conjunctival and corneal tumors in 99 patients with at least 6 months (mean, 22 months) of follow-up. The median age of the group ...

Skin malignancies are the most common cancers in the United States. 1 Typically, skin cancer is categorized as either melanoma or non­melanoma skin cancer, which is also known as keratinocyte ...

Personal cancer journey emphasizes the emotional and physical challenges faced by patients during diagnosis and treatment. Patient advocacy is crucial in navigating the healthcare system and making ...

Corrixr Therapeutics, a pre-clinical genetic medicine company targeting lung, head & neck, and esophageal squamous cell ...

A bispecific antibody that simultaneously targets PD-1 and VEGF extended overall survival by more than four months compared ...